Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Cited In for PubMed (Select 16954473)

1.

Can the breast screening appointment be used to provide risk assessment and prevention advice?

Evans DG, Howell A.

Breast Cancer Res. 2015 Jul 9;17(1):84. doi: 10.1186/s13058-015-0595-y.

2.

Inter-observer agreement according to three methods of evaluating mammographic density and parenchymal pattern in a case control study: impact on relative risk of breast cancer.

Winkel RR, von Euler-Chelpin M, Nielsen M, Diao P, Nielsen MB, Uldall WY, Vejborg I.

BMC Cancer. 2015 Apr 12;15:274. doi: 10.1186/s12885-015-1256-3.

3.

Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography.

Keller BM, McCarthy AM, Chen J, Armstrong K, Conant EF, Domchek SM, Kontos D.

BMC Cancer. 2015 Mar 18;15:143. doi: 10.1186/s12885-015-1159-3.

4.

One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk.

Kerlikowske K, Gard CC, Sprague BL, Tice JA, Miglioretti DL; Breast Cancer Surveillance Consortium.

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):889-97. doi: 10.1158/1055-9965.EPI-15-0035. Epub 2015 Mar 30.

PMID:
25824444
5.

Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy.

Cao Y, Rosner BA, Ma J, Tamimi RM, Chan AT, Fuchs CS, Wu K, Giovannucci EL.

Int J Cancer. 2015 Oct 1;137(7):1719-28. doi: 10.1002/ijc.29533. Epub 2015 Apr 23.

PMID:
25820865
6.

Prospective approach to breast cancer risk prediction in African American women: the black women's health study model.

Boggs DA, Rosenberg L, Adams-Campbell LL, Palmer JR.

J Clin Oncol. 2015 Mar 20;33(9):1038-44. doi: 10.1200/JCO.2014.57.2750. Epub 2015 Jan 26.

PMID:
25624428
7.

A permutation method to assess heterogeneity in external validation for risk prediction models.

Wang LY, Lee WC.

PLoS One. 2015 Jan 21;10(1):e0116957. doi: 10.1371/journal.pone.0116957. eCollection 2015.

8.

Polyacrylamide gels for invadopodia and traction force assays on cancer cells.

Jerrell RJ, Parekh A.

J Vis Exp. 2015 Jan 4;(95):52343. doi: 10.3791/52343.

PMID:
25590238
9.

The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.

McCarthy AM, Keller B, Kontos D, Boghossian L, McGuire E, Bristol M, Chen J, Domchek S, Armstrong K.

Breast Cancer Res. 2015 Jan 8;17:1. doi: 10.1186/s13058-014-0509-4.

10.

Emerging Concepts in Breast Cancer Risk Prediction.

Gierach GL, Yang XR, Figueroa JD, Sherman ME.

Curr Obstet Gynecol Rep. 2013 Mar;2(1):43-52.

11.

Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.

Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS, de Koning HJ, Kerlikowske K, Lehman CD, Tosteson AN.

Ann Intern Med. 2015 Feb 3;162(3):157-66. doi: 10.7326/M14-0692.

PMID:
25486550
12.

Risk determination and prevention of breast cancer.

Howell A, Anderson AS, Clarke RB, Duffy SW, Evans DG, Garcia-Closas M, Gescher AJ, Key TJ, Saxton JM, Harvie MN.

Breast Cancer Res. 2014 Sep 28;16(5):446. doi: 10.1186/s13058-014-0446-2. Review.

13.

Breast density measurements using ultrasound tomography for patients undergoing tamoxifen treatment.

Sak M, Duric N, Littrup P, Li C, Bey-Knight L, Sherman M, Boyd N, Gierach G.

Proc SPIE Int Soc Opt Eng. 2013 Mar 29;8675:86751E.

14.

Breast cancer detection with short-interval follow-up compared with return to annual screening in patients with benign stereotactic or US-guided breast biopsy results.

Johnson JM, Johnson AK, O'Meara ES, Miglioretti DL, Geller BM, Hotaling EN, Herschorn SD.

Radiology. 2015 Apr;275(1):54-60. doi: 10.1148/radiol.14140036. Epub 2014 Nov 25.

PMID:
25423143
15.

Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts.

Lee CI, Cevik M, Alagoz O, Sprague BL, Tosteson AN, Miglioretti DL, Kerlikowske K, Stout NK, Jarvik JG, Ramsey SD, Lehman CD.

Radiology. 2015 Mar;274(3):772-80. doi: 10.1148/radiol.14141237. Epub 2014 Oct 28.

PMID:
25350548
16.

Comparison of sound speed measurements on two different ultrasound tomography devices.

Sak M, Duric N, Littrup P, Bey-Knight L, Sherman M, Gierach G, Malyarenko A.

Proc SPIE Int Soc Opt Eng. 2014 Mar 20;9040:90400S.

17.

Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I.

Warwick J, Birke H, Stone J, Warren RM, Pinney E, Brentnall AR, Duffy SW, Howell A, Cuzick J.

Breast Cancer Res. 2014 Oct 8;16(5):451. doi: 10.1186/s13058-014-0451-5.

18.

Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.

Mayers JR, Wu C, Clish CB, Kraft P, Torrence ME, Fiske BP, Yuan C, Bao Y, Townsend MK, Tworoger SS, Davidson SM, Papagiannakopoulos T, Yang A, Dayton TL, Ogino S, Stampfer MJ, Giovannucci EL, Qian ZR, Rubinson DA, Ma J, Sesso HD, Gaziano JM, Cochrane BB, Liu S, Wactawski-Wende J, Manson JE, Pollak MN, Kimmelman AC, Souza A, Pierce K, Wang TJ, Gerszten RE, Fuchs CS, Vander Heiden MG, Wolpin BM.

Nat Med. 2014 Oct;20(10):1193-8. doi: 10.1038/nm.3686. Epub 2014 Sep 28.

19.

Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk.

Ahern CH, Shih YC, Dong W, Parmigiani G, Shen Y.

Br J Cancer. 2014 Oct 14;111(8):1542-51. doi: 10.1038/bjc.2014.458. Epub 2014 Aug 19.

PMID:
25137022
20.

Predicting invasive breast cancer versus DCIS in different age groups.

Ayvaci MU, Alagoz O, Chhatwal J, Munoz del Rio A, Sickles EA, Nassif H, Kerlikowske K, Burnside ES.

BMC Cancer. 2014 Aug 11;14:584. doi: 10.1186/1471-2407-14-584.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk